StockData
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc (XFOR) stock

XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30
$2.98−0.11 (-3.56%)

Close on Nov 18, 2026Market cap $295.46MP/E –Yield –

X4 Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

X4 Pharmaceuticals's total debt was $54.57M at Dec 31, 2023. For fiscal 2023 it was $54.57M, up 62.3% from the year before. The highest annual figure on record is $54.57M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$54.57M+62.3%
FY2022Dec 31, 2022$33.62M-0.9%
FY2021Dec 31, 2021$33.93M+2.3%
FY2020Dec 31, 2020$33.18M+65.9%
FY2019Dec 31, 2019$20.00M+100.0%
FY2018Dec 31, 2018$10.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$54.57M+273.2%
Q2 FY2023Jun 30, 2023$764.00K-91.1%
Q1 FY2023Mar 31, 2023$554.00K-83.8%
Q4 FY2022Dec 31, 2022$33.62M-0.9%
Q3 FY2022Sep 30, 2022$14.62M+2009.8%
Q2 FY2022Jun 30, 2022$8.61M-74.1%
Q1 FY2022Mar 31, 2022$3.42M-82.9%
Q4 FY2021Dec 31, 2021$33.93M+69.7%
Q3 FY2021Sep 30, 2021$693.00K-97.4%
Q4 FY2020Dec 31, 2020$33.18M+69.7%
Q4 FY2019Dec 31, 2019$20.00M+100.0%
Q3 FY2019Sep 30, 2019$20.00M–
Q2 FY2019Jun 30, 2019$26.35M–
Q1 FY2019Mar 31, 2019$19.55M–
Q4 FY2018Dec 31, 2018$10.00M–

More X4 Pharmaceuticals figures

See a number that looks wrong?